Program Committee
Personalized Medicine Conference 2026 • November 18 –19
Hyatt Regency Boston/Cambridge • Cambridge, MA
The Personalized Medicine Coalition acknowledges the incredible expertise of the Program Advisory Committee for its leadership in crafting a dynamic and purposeful agenda for the conference.
Ángel Alberich-Bayarri, Ph.D.
Co-Founder and CEO
Quibim
Lourdes Barrera, Ph.D.
Executive Director, Global Medical Affairs Oncology - Precision Medicine
Merck
Brian Caveney, M.D.
EVP & President, Early Development Research Laboratories & Chief Medical and Scientific Officer
Labcorp
Guillaume Cettou
Executive Director, Diagnostics
GSK
Todd Druley, MD, Ph.D.
Chief Medical Officer
Foundation Medicine
Andrea Ferris
President and Chief Executive Officer
LUNGevity Foundation
Megan P. Hall, Ph.D.
Vice President of Medical & Corporate Affairs, and Distinguished Scientist
Grail
Peter J. Hulick, MD, MMSc, FACMG
Chair of Personalized Medicine
Endeavor Health
Tricia Kenny, MPhil, BS
Director, Enterprise Collaborations
Thermo Fisher Scientific
Richard Knight, MBA
Past President
American Association of Kidney Patients
James W. Lillard, Ph.D.
Senior Associate Dean
Morehouse School of Medicine
Nikki Martin
Senior Director, Precision Medicine Initiatives
LUNGevity Foundation
Howard McLeod, Pharm.D.
John Millholland, Ph.D.
Director, Diagnostic Sciences
BMS
Alasdair Milton, Ph.D.
Partner / Principal
KPMG, Healthcare & Life Sciences
Sharon Moulis, Ph.D.
Head of Companion Diagnostics and Clinical Assays
Pfizer
Lincoln Nadauld, M.D., Ph.D.
Chief Data Officer
Valinor
Omar Perez, Ph.D.
Head of Medical Diagnostics
US Medical Affairs Oncology
Sandy Prucka
Senior Director – Global Diagnostics Environment
Eli Lilly
Apostolia M. Tsimberidou, M.D., Ph.D.
Professor, Department of Investigational Therapeutics
The University of Texas MD Anderson Cancer Center
Sheila Walcoff
Founder & CEO
Goldbug Strategies, LLC
Michael Ybarra, M.D.
Chief Medical Officer
PhRMA